Use of anti-aging glycopeptides for inhibition of immune rejection of a graft
AssigneeProtokinetix Inc.
InventorLachlan Grant YOUNG
Life of this patent
Estimating the term…
Abstract
The present document describes uses and methods of using a gem-difluorinated C-glycopeptide compound of general formula I, or a pharmaceutically acceptable base, addition salt with an acid, hydrate or solvate of the compound of general formula I for inhibition or prevention of immune rejection of an isolated graft contacted with said compound, prior to transplantation in a subject in need thereof.
Claims25
A method for inhibition or prevention of immune rejection of a graft comprising the step of:
- a) contacting an isolated graft prior to a transplantation in a subject in need thereof, with a gem-difluorinated C-glycopeptide compound of general formula I, or a pharmaceutically acceptable base, addition salt with an acid, hydrate or solvate of the compound of general formula I:
- in which:
- N is an integer between 1 and 5,
- R4═H, AA1, or AA1-AA2,
- R5═OH, AA1, or AA1-AA2,
- AA1 and AA2 independently represent amino acids with a non-polar side chain and
- R1, R2, R3 are independent groups in which two of R1, R2 and R3 are selected from H, CH3, CH2Ph, CH(CH3)2, CH2CH(CH3)2 or CH(CH3)CH2CH3 and the remaining R1, R2, R3 is
- in which:
- n is an integer between 3 and 4,
- Y, Y′ are independent groups
- in which Y, Y′ ═H, OR, N3, NR′R″, or SR′″,
- where R═H, benzyl, trimethylsilyl, tert-butyldimethylsilyl, tert-butyldiphenylsilyl or acetate group,
- R′, R″ independently=H, alkyl, allyl, benzyl, tosylate group, C(═O)-alkyl or C(═O)—Bn,
- R′″═H, alkyl, or acetate group,
- R6 is H, CH3, CH2OH, CH2-glycoside group or CH2—OGP in which GP is a protector group selected from alkyl, benzyl, trimethylsilyl, tert-butyldimethylsilyl, tert-butyldiphenylsilyl, or acetate group,
- R7═OH, OGP′, NH2, N3, NHGP′ or NGP′GP″ in which GP′ and GP″ are independently selected from alkyl, benzyl, trimethylsilyl, tert-butyldimethylsilyl, tert-butyldiphenylsilyl, or acetate group,
- R8 is a hydrogen atom H or a free or protected alcohol function, and
- if R1═R2═H, CH3, CH2Ph, CH(CH3)2, CH2CH(CH3)2, or CH(CH3)CH2CH3
- then R3=
- in which:
- n is an integer between 3 and 4,
- Y, Y′ are independent groups
- in which Y, Y′ ═H, OR, N3, NR′R″, or SR′″,
- where R═H, benzyl, trimethylsilyl, tert-butyldimethylsilyl, tert-butyldiphenylsilyl, or acetate group,
- R′, R″ independently=H, alkyl, allyl, benzyl, tosylate group, C(═O)-alkyl, or C(═O)—Bn,
- R′″═H, alkyl, or acetate group,
- R6 is H, CH3, CH2OH, CH2-glycoside group, or CH2—OGP in which GP is a protector group selected from alkyl, benzyl, trimethylsilyl, tertbutyldimethylsilyl, tert-butyldiphenylsilyl, or acetate group,
- R7═OH, OGP′, NH2, N3, NHGP′, or NGP′GP″ in which GP′ and GP″ are independently selected from alkyl, benzyl, trimethylsilyl, tertbutyldimethylsilyl, tert-butyldiphenylsilyl, or acetate group,
- R8 is a hydrogen atom H or a free or protected alcohol function,
- if R1═R3═H, CH3, CH2Ph, CH(CH3)2, CH2CH(CH3)2, or CH(CH3)CH2CH3
- then R2=
- in which:
- n is an integer between 3 and 4,
- Y, Y′ are independent groups
- in which Y, Y′ ═H, OR, N3, NR′R″, or SR′″,
- where R═H, benzyl, trimethylsilyl, tert-butyldimethylsilyl, tert-butyldiphenylsilyl, or acetate group,
- R′, R″ independently=H, alkyl, allyl, benzyl, tosylate group, C(═O)-alkyl, or C(═O)—Bn,
- R′″═H, alkyl, or acetate group,
- R6 is H, CH3, CH2OH, CH2-glycoside group, or CH2—OGP in which GP is a protector group selected from alkyl, benzyl, trimethylsilyl, tert-butyldimethylsilyl, tert-butyldiphenylsilyl, or acetate group,
- R7═OH, OGP′, NH2, N3, NHGP′, or NGP′GP″ in which GP′ and GP″ are independently selected from alkyl, benzyl, trimethylsilyl, tertbutyldimethylsilyl, tert-butyldiphenylsilyl, or acetate group,
- R8 is a hydrogen atom H or a free or protected alcohol function,
- if R2═R3═H, CH3, CH(CH3)2, CH2CH(CH3)2, or CH(CH3)CH2CH3
- then R1=
- in which:
- n is an integer between 3 and 4,
- Y, Y′ are independent groups
- in which Y, Y′ H, OR, N3, NR′R″, or SR′″,
- where R═H, benzyl, trimethylsilyl, tert-butyldimethylsilyl, tert-butyldiphenylsilyl, or acetate group,
- R′, R″ independently=H, alkyl, allyl, benzyl, tosylate group, C(═O)-alkyl, or C(═O)—Bn,
- R′″═H, alkyl, or acetate group,
- R6 is H, CH3, CH2OH, CH2-glycoside group, or CH2—OGP in which GP is a protector group selected from alkyl, benzyl, trimethylsilyl, tert-butyldimethylsilyl, tert-butyldiphenylsilyl, or acetate group,
- R7═OH, OGP′, NH2, N3, NHGP′, or NGP′GP″ in which GP′ and GP″ are independently selected from alkyl, benzyl, trimethylsilyl, tertbutyldimethylsilyl,
- tert-butyldiphenylsilyl, or acetate group,
- R8 is a hydrogen atom H or a free or protected alcohol function
- b) transplanting said graft in said subject in need thereof, said subject in need thereof being under an immune suppressant drug therapy to inhibit or prevent immune rejection of said graft;
- c) discontinue said immune suppressant drug therapy after a time sufficient for implantation of said graft in said subject in need thereof.
12-13. (canceled)
(canceled)
(canceled)
The method of claim 13, wherein said isolated cell is a neurosensory precursor cell for treating a retinal degenerative disease.
26-102. (canceled)
Dependencies are inferred from the claim text.